Date: October 15th, 2024.
Time: 14.00-16.00 CET
14:00-14:10 – Brief introduction by WG5 leaders (Dr. Barbara Breznick and Prof. Rosalinda Sorrentino) and Prof. Emmet Mc Cormack (University of Bergen, Norway)
14:10-14:30 – Preclinical development of immunoncology therapeutics in humanized mice
Dr. Michael Boice, Senior Director, Scientific Engagement, Certis Oncology Solutions, San Diego, USA
14:30-14:50 –Preclinical development of small molecule immunoncology therapeutics – A pharma perspective
Dr. Katarzyna Wnuk-Lipinska, Novartis Biomedical Research, Basel, Switzerland
14:50-15:10 – Development of immunoncology therapeutics in preparation for IND.
Dr. Hillary Millar Quinn, Director of In Vivo Pharmacology at Century Therapeutics Inc., Philadelphia, USA
15:10-16:00 – Q&A-Discussion
Check out Webinar here.
